Emerald Acquisition’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
$10.7M Sell
204,006
-27,548
-12% -$1.45M 0.02% 833
2016
Q2
$9.58M Buy
+231,554
New +$9.58M 0.02% 953